NCT01941953View on ClinicalTrials.gov

Metformin and 5-fluorouracil for Refractory Colorectal Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

March 31, 2015

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Metformin and Fluorouracil

metformin 850mg PO BID plus 5FU 425mg/m2 + leucovorin 50mg IV weekly

Trial Locations (1)

01246-000

Instituto Do Cancer Do Estado de São Paulo, São Paulo

All Listed Sponsors
lead

Instituto do Cancer do Estado de São Paulo

OTHER

NCT01941953 - Metformin and 5-fluorouracil for Refractory Colorectal Cancer. | Biotech Hunter | Biotech Hunter